marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
HOOKIPA Pharma Financial Ratios 2011-2024 | HOOK
Annual Financial Ratios HOOKIPA Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.8 | -0.8 | -1.0 | -6.6 | -5.3 | - | - | - | - | - | - | - | - |
P/S |
3.3 | 3.8 | 4.1 | 14.7 | 18.9 | - | - | - | - | - | - | - | - |
EPS |
-0.9 | -1.0 | -2.3 | -1.7 | -2.4 | -17.8 | -13.9 | - | - | - | - | - | - |
EV (Enterprise Value) |
21.5 M | 9.82 M | 46 M | 177 M | 139 M | -24.7 M | 55 M | - | - | - | - | - | - |
EBITDA per Share |
-1 | -1.06 | -2.35 | -1.89 | -2.4 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-0.5 | -3.6 | -2.7 | - | - | - | - | - | - | - | - | ||
PEG |
- | -2.72 | -0.04 | - | - | - | - | - | - | - | - | ||
P/B |
0.7 | 0.5 | 0.9 | 1.8 | 1.9 | - | - | - | - | - | - | - | - |
P/CF |
-1.2 | -2.7 | -1.2 | -7.3 | -5.2 | - | - | - | - | - | - | - | - |
ROE % |
-90.79 | -63.32 | -84.46 | -28.24 | -36.50 | - | - | - | - | - | - | - | - |
ROA % |
-50.56 | -38.08 | -60.03 | -23.47 | -29.94 | - | - | - | - | - | - | - | - |
ROCE % |
-81.86 | -54.26 | -83.01 | -31.97 | -34.38 | - | - | - | - | - | - | - | - |
Current Ratio |
2.3 | 2.5 | 3.5 | 5.9 | 8.7 | - | - | - | - | - | - | - | - |
DSO |
63.9 | 172.0 | 123.0 | 66.0 | 297.3 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
63.9 | 172.0 | 123.0 | 66.0 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
63.9 | 172.0 | 123.0 | 66.0 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios HOOKIPA Pharma
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.1 | -1.52 | -1.73 | -2.18 | -0.27 | - | -0.25 | -0.23 | -0.4 | - | -0.61 | -0.52 | -0.53 | -0.46 | -0.53 | -0.28 | -0.43 | -0.4 | -0.45 | -0.63 | -9.27 | -2.05 | -4.34 | -6.38 | -5.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | -0.3 | - | -0.25 | -0.23 | -0.42 | - | -0.54 | -0.52 | -0.55 | - | -0.52 | -0.29 | -0.45 | - | -0.49 | -0.67 | -10.3 | - | -5.58 | -7.33 | -6.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-77.56 | -81.86 | -75.80 | -71.87 | -68.22 | -40.67 | -59.21 | -61.62 | -62.85 | -44.47 | -52.46 | -62.17 | -76.79 | -92.73 | -93.43 | -101.65 | -109.88 | -118.10 | -106.28 | -63.26 | -17.15 | 26.89 | 23.76 | 17.21 | 7.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-48.94 | -48.39 | -45.18 | -45.62 | -45.69 | -30.74 | -44.84 | -46.87 | -47.70 | -34.56 | -41.20 | -50.59 | -63.75 | -77.08 | -77.57 | -84.00 | -90.43 | -96.87 | -92.51 | -68.39 | -47.00 | -23.79 | -21.02 | -15.23 | -6.70 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-79.26 | -75.35 | -68.98 | -67.34 | -65.23 | -41.69 | -60.01 | -61.60 | -63.47 | -45.70 | -55.54 | -47.06 | -38.02 | -22.85 | -33.38 | -34.06 | -39.09 | -29.35 | -18.51 | 2.85 | 27.04 | 37.05 | 37.05 | 26.21 | 12.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.9 | 3.2 | 2.4 | 2.4 | 2.0 | 2.5 | 4.0 | 4.3 | 4.1 | 3.5 | 4.2 | 4.1 | 5.7 | 5.9 | 5.9 | 5.9 | 5.9 | 5.6 | 5.6 | 5.6 | 5.6 | 2.9 | 2.9 | 2.9 | 2.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
3.9 | 26.8 | 6.2 | 12.9 | 101.0 | - | 39.5 | 31.4 | 239.9 | - | 87.7 | 78.1 | 84.6 | 98.0 | 125.2 | 75.7 | 87.4 | 38.8 | 68.8 | 34.6 | 131.8 | 88.4 | 236.2 | 691.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
3.9 | 26.8 | 6.2 | 12.9 | 101.0 | - | 39.5 | 31.4 | 239.9 | - | 87.7 | 78.1 | 84.6 | 98.0 | 125.2 | 75.7 | 87.4 | 38.8 | 68.8 | 34.6 | 131.8 | 88.4 | 236.2 | 691.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
3.9 | 26.8 | 6.2 | 12.9 | 101.0 | - | 39.5 | 31.4 | 239.9 | - | 87.7 | 78.1 | 84.6 | 98.0 | 125.2 | 75.7 | 87.4 | 38.8 | 68.8 | 34.6 | 131.8 | 88.4 | 236.2 | 691.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency